The global Neurodiagnostics Market is anticipated to reach at USD 18.3 billion by 2024. Neurodiagnostics are also known as “Neurodiagnostic tests”. They diagnose neurological disorders such as migraine, Parkinson’s disease, stroke, ischemic stroke and epilepsy. The factors that propel the growth of the Neurodiagnostics Market include increasing occurrence of neurological disorders such as stroke, growing consciousness among people and technological developments. On the other hand, there are factors that may hamper the growth of the market including lack of mental health checkup & regular diagnosis in emerging countries. Neurodiagnostics industry is anticipated to grow at a significant CAGR in the upcoming period as the scope, product types, and its applications are increasing across the globe.
Request Sample Copy of This Market Research @
https://www.millioninsights.com/industry-reports/neurodiagnostics-market/request-sample
The
market may be explored by product type, end users, technology, and geography.
The industry may be explored by product type as intracranial pressure monitor,
Electromyography (EMG), Electroencephalogram (EEG), Transcranial Doppler, and
Cerebral oximeters. The “Electroencephalogram (EEG)” segment led the
Neurodiagnostics Market in 2015 and is anticipated to maintain its dominance by
2024.The key factor that could be attributed to the growth of market includes
capacity to efficiently diagnoze epilepsy and the other neurological disorders
through non-invasive methods.
Neurodiagnostics
industry may be explored by technology as neuroimaging technologies that may
further include Nuclear Medicine Imaging (SPECT, PET), Magnetic Resonance
Imaging (MRI), Computed Tomography (CT), Electroencephalography (EEG), Near
Infrared Spectroscopic Imaging (NIRS), Voxel-based Morphometry (VBM), and
Magnetoencephalography (MEG) in vitro diagnostics, and neuroinformatic.
Browse Full Research Report @
https://www.millioninsights.com/industry-reports/neurodiagnostics-market
The
“CT and MRI” segment led the neurodiagnostics industry in 2015 and is
anticipated to maintain its dominance by 2024.The factors that could be
attributed to the growth of the segment might include increasing adoption in
the internal body surgeries. The market could be explored based on end users as
hospitals, operation theatres, neurophysiological
laboratories and clinics.
North
America accounted for the major share of the Neurodiagnostics Market Size in
2015 and will continue to lead in the forecast period. The factors that could
be attributed to the growth include increasing acceptance of neurodiagnostics
technology.
Some
of the key players that fuel the growth of the neurodiagnostics industry
comprise Alpha Omega Ltd., Bruker, Guerbet, Agilent Technologies, Fonar
Corporation, Doric Lenses, Inc., GE Healthcare, Hitachi Medical Corporation,
Hologic Inc., Mightex Systems, NeuroNexus Technologies, Neusoft Medical Systems
Co., Ltd., Roche Diagnostics, Plexon, Inc., Philips Healthcare, Siemens
Healthcare and Toshiba Medical Systems Corporation. The leading companies are
taking up partnerships, mergers and acquisitions, and joint ventures in order
to boost the inorganic growth of the industry.
Comments
Post a Comment